Pluto Bioinformatics

GSE124716: Comparison of Prox1 expressing and Prox1 knockout intestinal tumors and the effect of A2V+CD40

Bulk RNA sequencing

Control or A2V+CD40 treated Prox1-proficient (AP) and Prox1-deficient (APP) tumors SOURCE: Tatiana Petrova (tatiana.petrova@unil.ch) - Vascular and Tumor Biology Lab University of Lausanne